Independent Advisory Panel

All RIQAS participants have access to an independent advisory panel consisting of several scientific and clinical experts. The independent advisory panel ensures the RIQAS scheme is conducted in a professional and ethical way it also guarantees participant confidentiality.

John Williams D.Phil, MBA, FAMLS.
Pathology Manager - John Williams

Speciality: Clinical Biochemistry. Present position: Pathology Manager at Sligo General Hospital (SGH), Ireland. Member of the board of the Research and Education Foundation at S.G.H; chairman of the Research Advisory Committee and the Research Ethics Committee. John Williams has over thirty peer reviewed publications and is on the editorial board of the British Journal of Biomedical Science. He has been a member of the RIQAS advisory panel since 1999.


Julia Anderson MBChB BSc (Hons) MD FRCPEdin FRCPath
Dr. Julia Anderson

After qualifying from Edinburgh University Medical School, Dr. Anderson trained in General Medicine in Edinburgh, prior to specialising in Haematology. During her Haematology training she carried out basic science research at the Henderson Research Centre, affiliated to McMaster University, Hamilton, Ontario. Dr. Anderson became Director of the Northern Ireland Comprehensive Care Haemophilia and Thrombosis Centre in 2000 and directed a comprehensive care centre in Belfast for the management of over 400 patients with congenital bleeding and thrombophilic disorders. In 2004, she returned to Canada and held joint Clinical and Faculty positions as Consultant Haematologist at Hamilton General Hospital, and Assistant Professor, Division of Haematology and Thromboembolism, Medicine, McMaster University. She returned to Edinburgh in 2008 and is currently working as Consultant Haematologist at the Royal Infirmary of Edinburgh. She is Chair of the NHS Lothian Thrombosis Committee and has research interests in bleeding in the elderly, and acquired bleeding disorders. She is a Fellow of the Royal College of Physicians of Edinburgh and a Fellow of the Royal College of Pathologists (UK), and continues to hold a part-time appointment as Associate Professor in the Department of Medicine at McMaster University.

Dr. Mark Piper, BSc PhD

Mark has 5 years experience heading an ISO/IEC 17025 accredited toxicology laboratory providing services for clinical, workplace and forensic toxicology clients, including various United Kingdom police forces. Reporting officer and expert witness for forensic toxicology analysis and interpretation for drug and alcohol related cases. In addition to this he has over 10 years experience in research and development of clinical and forensic toxicology analytical testing products covering a range of specimen matrix types including urine, blood, oral fluids, meconium, vitreous humour and tissue homogenates. Mark has also been involved in multiple successful US FDA 510(k) premarket notification submissions for toxicology analytical products and multiple external collaboration projects co-ordinating external analytical method comparisons at independent laboratories worldwide. He is a regular conference delegate and presenter at international symposia including: Society of Forensic Toxicologists, American Academy of Forensic Science, The International Association of Forensic Toxicologists, The Forensic Science Society and Eurotox and a member of The Society of Forensic Toxicologists.

Peter Coyle

Dr. Coyle, a Consultant Virologist and Clinical Director-Laboratories, at the Virus Reference Laboratory, part of The Royal Group of Hospitals, Belfast will soon be joining the RIQAS advisory panel.